Antisense epidermal growth factor oligodeoxynucleotides inhibit follicle-stimulating hormone-induced in vitro DNA and progesterone synthesis in hamster preantral follicles.
Whether FSH-induced follicular DNA synthesis in the hamster involves epidermal growth factor (EGF) message induction and translation was evaluated using antisense EGF oligodeoxynucleotides. The 15 base pair antisense oligomers synthesized according to mouse EGF cDNA sequence downstream from the 5'-ATG start site hybridized with a 4.4-kilobase message of mouse submaxillary glands and with 4.0 kilobases of mRNA of hamster submaxillary glands, kidney, and ovaries. Preantral follicles at stages 1-7 were enzymatically and mechanically isolated from adult, cyclic hamsters on day 4:0900 h (day 1 = estrus), and follicles at stages 1-5 were isolated from hamsters hypophysectomized for 10 days. Follicles were preexposed to either antisense or sense EGF thio-oligomers for 1, 12, or 24 h and then cultured for an additional 24 h in the absence or presence of ovine-FSH (100 ng/ml) or recombinant murine EGF (50 ng/ml), and 1 microCi/ml [3H]thymidine. Follicular [3H]thymidine incorporation and EGF and steroid (progesterone, androstenedione, and 17 beta-estradiol) production were monitored to assess the molecular mechanism of FSH regulation of follicular development. Antisense oligomers significantly inhibited FSH-induced follicular DNA synthesis and progesterone but not androgen or estrogen production with a latency of 24 h. The oligomer inhibition of FSH action was effectively reversed by exogenous EGF. Antisense oligomers significantly inhibited follicular EGF synthesis in vitro. These results suggest that EGF message is expressed in the hamster ovary, and one of the molecular mechanisms of FSH regulation of hamster preantral folliculogenesis involves EGF mRNA induction and translation.(ABSTRACT TRUNCATED AT 250 WORDS)
Leland J. and Dorothy H. Olson Center for Women's Health, Department of Obstetrics and Gynecology, University of Nebraska Medical Center, Omaha 68198-4515.
S K
SK
Roy
S G
SG
Harris
D000595:Amino Acid Sequence; D000818:Animals; D001483:Base Sequence; D006224:Cricetinae; D004261:DNA Replication / Q000187:drug effects*; D016373:DNA, Antisense / Q000494:pharmacology*; D003864:Depression, Chemical; D004815:Epidermal Growth Factor / Q000235:genetics* / Q000494:pharmacology / Q000502:physiology; D005260:Female; D005640:Follicle Stimulating Hormone / Q000037:antagonists & inhibitors*; D005786:Gene Expression Regulation / Q000187:drug effects; D006107:Granulosa Cells / Q000187:drug effects / Q000378:metabolism; D008647:Mesocricetus; D008969:Molecular Sequence Data; D006080:Ovarian Follicle / Q000187:drug effects* / Q000378:metabolism; D011374:Progesterone / Q000096:biosynthesis*; D011994:Recombinant Proteins / Q000494:pharmacology
D016373:DNA, Antisense; D011994:Recombinant Proteins; D011374:Progesterone; D004815:Epidermal Growth Factor; D005640:Follicle Stimulating Hormone